Your browser doesn't support javascript.
loading
Recent Biomaterial-Assisted Approaches for Immunotherapeutic Inhibition of Cancer Recurrence.
Mozafari, Negin; Jahanbekam, Sheida; Ashrafi, Hajar; Shahbazi, Mohammad-Ali; Azadi, Amir.
Afiliación
  • Mozafari N; Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, 71468 64685 Shiraz, Iran.
  • Jahanbekam S; Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, 71468 64685 Shiraz, Iran.
  • Ashrafi H; Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, 71468 64685 Shiraz, Iran.
  • Shahbazi MA; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, Netherlands.
  • Azadi A; Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, 71468 64685 Shiraz, Iran.
ACS Biomater Sci Eng ; 10(3): 1207-1234, 2024 03 11.
Article en En | MEDLINE | ID: mdl-38416058
ABSTRACT
Biomaterials possess distinctive properties, notably their ability to encapsulate active biological products while providing biocompatible support. The immune system plays a vital role in preventing cancer recurrence, and there is considerable demand for an effective strategy to prevent cancer recurrence, necessitating effective strategies to address this concern. This review elucidates crucial cellular signaling pathways in cancer recurrence. Furthermore, it underscores the potential of biomaterial-based tools in averting or inhibiting cancer recurrence by modulating the immune system. Diverse biomaterials, including hydrogels, particles, films, microneedles, etc., exhibit promising capabilities in mitigating cancer recurrence. These materials are compelling candidates for cancer immunotherapy, offering in situ immunostimulatory activity through transdermal, implantable, and injectable devices. They function by reshaping the tumor microenvironment and impeding tumor growth by reducing immunosuppression. Biomaterials facilitate alterations in biodistribution, release kinetics, and colocalization of immunostimulatory agents, enhancing the safety and efficacy of therapy. Additionally, how the method addresses the limitations of other therapeutic approaches is discussed.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Materiales Biocompatibles / Neoplasias Idioma: En Revista: ACS Biomater Sci Eng Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Materiales Biocompatibles / Neoplasias Idioma: En Revista: ACS Biomater Sci Eng Año: 2024 Tipo del documento: Article